APA (7th ed.) Citation

LH, K., AT, M., BJ, Y., JW, W., & JW, H. (2025). Retraction notice to "Development of Angiotensin IV Analogs as Hepatocyte Growth Factor/Met Modifiers" [J Pharmacol Exp Ther 340 (2012) 539-548]. The Journal of pharmacology and experimental therapeutics, 392(4), 103566. https://doi.org/10.1016/j.jpet.2025.103566

Chicago Style (17th ed.) Citation

LH, Kawas, McCoy AT, Yamamoto BJ, Wright JW, and Harding JW. "Retraction Notice to "Development of Angiotensin IV Analogs as Hepatocyte Growth Factor/Met Modifiers" [J Pharmacol Exp Ther 340 (2012) 539-548]." The Journal of Pharmacology and Experimental Therapeutics 392, no. 4 (2025): 103566. https://doi.org/10.1016/j.jpet.2025.103566.

MLA (9th ed.) Citation

LH, Kawas, et al. "Retraction Notice to "Development of Angiotensin IV Analogs as Hepatocyte Growth Factor/Met Modifiers" [J Pharmacol Exp Ther 340 (2012) 539-548]." The Journal of Pharmacology and Experimental Therapeutics, vol. 392, no. 4, 2025, p. 103566, https://doi.org/10.1016/j.jpet.2025.103566.